WALTHAM, Mass., Jan. 15 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO), the world leader in serving science, today
announced it has acquired SwissAnalytic Group AG, based in Basel,
Switzerland. SwissAnalytic Group owns Spectronex AG and Flux Instruments
AG, which had combined revenue of approximately $22 million USD in fiscal
year 2006.
Spectronex is a leading supplier of mass spectrometry, chromatography
and surface science instrumentation in Switzerland, Austria, Slovakia and
the Czech Republic. As Thermo Fisher Scientific expands its field sales
presence in Europe, this acquisition will bring additional direct sales,
demonstration capabilities and visibility to customers in these regions.
Flux Instruments is a manufacturer of high performance liquid
chromatography (HPLC) pumps and software. Flux brings new technology and
design expertise to Thermo Fisher Scientific's current HPLC and LCMS
business, which includes the new Thermo Scientific Accela(TM) UHPLC as well
as advanced sample extraction and liquid chromatography products gained
through the recent acquisition of Cohesive Technologies. Flux will enhance
the company's product portfolio with complementary technologies and
intellectual property for future product development.
"Flux Instruments is a strong complement to our expanding
chromatography and life sciences mass spectrometry product lines," said
Marijn E. Dekkers, president and chief executive officer of Thermo Fisher
Scientific. "In addition, Spectronex enables Thermo Fisher to strengthen
our footprint in Europe with direct sales channels and support, enhancing
our ability to work closely with important customers in this area."
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, enabling our customers to make the world healthier,
cleaner and safer. With annual sales of more than $9 billion, we employ
30,000 people and serve over 350,000 customers within pharmaceutical and
biotech companies, hospitals and clinical diagnostic labs, universities,
research institutions and government agencies, as well as environmental and
industrial process control settings. Serving customers through two premier
brands, Thermo Scientific and Fisher Scientific, we help solve analytical
challenges from routine testing to complex research and discovery. Thermo
Scientific offers customers a complete range of high-end analytical
instruments as well as laboratory equipment, software, services,
consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com.
The following constitutes a "Safe Harbor" statement under the Private
Securities Litigation Reform Act of 1995: This press release contains
forward- looking statements that involve a number of risks and
uncertainties. Important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements include
those discussed in Thermo Electron and Fisher Scientific's Quarterly
Reports on Form 10-Q for the third quarter of 2006 under the caption "Risk
Factors," both of which are on file with the Securities and Exchange
Commission and available in the "Investors" section of our Website under
the heading "SEC Filings." We also may make forward-looking statements
about the benefits of the merger of Thermo Electron and Fisher Scientific,
including statements about future financial and operating results, the new
company's plans, objectives, expectations and intentions and other
statements that are not historical facts. Important factors that could
cause actual results to differ materially from those indicated by
forward-looking statements include risks and uncertainties relating to: the
risk that the businesses will not be integrated successfully; the risk that
the cost savings and any other synergies from the transaction may not be
fully realized or may take longer to realize than expected; disruption from
the transaction making it more difficult to maintain relationships with
customers, employees or suppliers; competition and its effect on pricing,
spending, third-party relationships and revenues; the need to develop new
products and adapt to significant technological change; implementation of
strategies for improving internal growth; use and protection of
intellectual property; dependence on customers' capital spending policies
and government funding policies; realization of potential future savings
from new productivity initiatives; dependence on customers that operate in
cyclical industries; general worldwide economic conditions and related
uncertainties; the effect of changes in governmental regulations; exposure
to product liability claims in excess of insurance coverage; and the effect
of exchange rate fluctuations on international operations. While we may
elect to update forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if our estimates change
and, therefore, you should not rely on these forward-looking statements as
representing our views as of any date subsequent to today.
Media Contact Information: Investor Contact Information:
Lori Gorski Ken Apicerno
Phone: 781-622-1242 Phone: 781-622-1111
E-mail: E-mail:
lori.gorski@thermofisher.com ken.apicerno@thermofisher.com
Website: http://www.thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com
http://www.prnewswire.com/comp/877850.html /
CONTACT:
Media, Lori Gorski, +1-781-622-1242, or
lori.gorski@thermofisher.com, or Investors, Ken Apicerno,
+1-781-622-1111, or ken.apicerno@thermofisher.com, both of Thermo
Fisher Scientific Inc.
|
